Industry Context: The Rising Bar for Supplement Contract Manufacturing

IVC Nutrition Corporation (IVC) is a global CDMO in the VMS (Vitamins, Minerals and Supplements) and OTC market, operating 9 international manufacturing sites and partnering with customers in more than 80 countries. As the dietary supplement contract manufacturing market continues to expand, buyers increasingly evaluate suppliers on verifiable certifications, production parameters, and multi-format capability rather than price alone.

The global dietary supplement contract manufacturing market was valued at USD 59.63 billion in 2024 and is projected to reach USD 121.2 billion by 2030, according to Grand View Research. This growth is accompanied by tighter regulatory expectations and a broader product mix, making supplier qualification a more demanding exercise.

Figure 1: IVC operates production in GMP-grade clean areas designed to meet international compliance standards.

Company Overview: A Global CDMO with Multi-Format Depth

IVC Nutrition Corporation (IVC) is a contract development and manufacturing organization (CDMO) for vitamins, minerals, and supplements, with manufacturing sites spanning the US, Canada, UK, Germany, and China. The company employs more than 5,000 people globally and reports an annual output of 400 million jars/bottles, 52 billion tablets, 6 billion hard capsules, 1 billion probiotic sticks, 4.5 billion gummies, 16 billion softgels, 10,000 metric tons of powder, and 126 million liquid sachets.

IVC’s R&D team includes more than 100 engineers, and the company’s facility footprint covers 118,545 square meters. The company states that roughly 50% of its products are exported, with main markets in the EU, USA, and APAC.

In the US private-label segment, IVC is recognized as the #1 Private Label VMS supplier by Circana (Total MULO) for the 52 weeks ending March 24, 2024, according to IVC Global data cited in the company’s public profile.

The Sourcing Challenge: What Buyers Must Verify

For procurement teams evaluating a dietary supplement contract manufacturer, the core question is not simply whether a supplier can produce a product, but whether it can do so while meeting market-specific certification, format, and quality parameters. A manufacturer’s certifications determine its eligibility for certain markets, while production parameters affect dosage design, packaging, and shelf life.

In the United States, all dietary supplement manufacturers must comply with 21 CFR Part 111, which defines current Good Manufacturing Practice (cGMP) for dietary supplements. Beyond that baseline, suppliers targeting global markets often hold voluntary third-party certifications such as NSF, BRC, IFS, SSCI, and TGA GMP to demonstrate compliance across multiple jurisdictions.

Certifications and Compliance: A Detailed Map

IVC Nutrition Corporation holds a portfolio of certifications that cover several major markets and product formats. These certifications are supported by documented scope definitions, certificate numbers, and issuing authorities.

The SSCI certification covers dietary supplements in the form of capsules, ingestible liquids, tablets, and other (granule and gummy), and is based on the SSCI Technical Benchmarking Requirements, SSCI Social Compliance Framework, and ESG standards. The TGA GMP certification applies to the manufacture of medicines, including full product manufacture excluding packaging and labelling, and is based on the PIC/S Guide to Good Manufacturing Practice for Medicinal Products. The NSF certification for the Softgel product is to NSF/ANSI 455-2 - 2024, which incorporates 21 CFR Part 111, 21 CFR Part 117, 21 CFR Part 11, and 21 CFR Part 1 Subparts L and O.

The Capsule product holds IFS Food certification to version 8, April 2023, at Higher Level with a score of 96.70%. The BRC certification covers the manufacturing of dietary supplements including vitamins, minerals, glucosamine, and natural vegetable extract under the BRC Global Standard for Food Safety - 15 - Dried food and ingredients.

Product Formats and Technical Parameters

IVC’s product range spans tablets, hard capsules, softgels, gummies, chewable burstlets, probiotics, and liquids. For buyers evaluating a specific format, IVC provides reference parameters that can be used to align product design with market needs.

Tablet production includes Oval, Oblong, Round, and Special-shaped models. Tablets can be packed at 60-1000 tablets per bottle, with a net weight range of 200mg-2900mg per tablet, and a shelf life of 24 to 36 months. Hard capsules are available in sizes from 000# to 5#, with a count of 60-1000 capsules per bottle and a net weight range of 350mg-1200mg total per capsule; capsule materials include gelatin and vegetarian options.

Softgel shapes include Oblong, Oval, Calabash, Bone, and Heart, with 60-450 softgels per bottle and a net weight range of 250mg-1200mg per softgel. Gummies are offered in a wide range of shapes—from Small Conical, Dome Disk, and Bear to Heart-shaped, Ring, and Cat Paw—with 60-260 gummies per bottle and a net weight of 2g-7g per gummy. Chewable Burstlets are available in Ball, Fish, and Calabash shapes, with 60-450 burstlets per bottle and 250mg-1200mg net weight per burstlet.

Figure 2: Gummies and other non-pill formats are a growing area of supplement product development, and IVC produces a range of registered formats.

Across formats, IVC commonly uses pharmaceutical-grade HDPE bottles, aluminum blister packaging, and child-resistant closures. Shelf life varies by format: gummies are typically labeled at 12 to 24 months, while tablets, capsules, softgels, and burstlets are typically labeled at 24 to 36 months from production date.

Manufacturing Capabilities and Quality Systems

IVC’s production facilities are designed around GMP cleanliness standards. The company’s application profile lists capabilities in solid dosage manufacturing, including mixing and blending, dry formulation, tablet compression, encapsulation, and functional coating; liquid dosage manufacturing for solutions, suspensions, and emulsions; in-process control; microbiological testing; physical and chemical analysis; equipment qualification and calibration; stability studies; GMP documentation and batch release; and primary and secondary packaging.

Production is automated, with high-speed automated tablet pressing and automated capsule filling operations. IVC reports that its quality control process includes 100% testing. The company also maintains a state-of-the-art QC lab and offers after-sales support, including assistance with award applications.

Figure 3: IVC’s global manufacturing network spans multiple sites, supporting regional compliance and supply resilience.

Capacity, MOQ, and Lead Time

For buyers moving from research to evaluation, capacity and minimum order quantity (MOQ) are practical decision criteria. IVC’s monthly capacity is approximately 4.33 billion tablets, 500 million hard capsules, 83.33 million sachets of probiotics, 375 million gummies, 1.33 billion capsules, 833 metric tons of powder, and 10.5 million liquid sachets.

The MOQ for IVC is 0.3 million tablets, 1 million capsules, and 0.6 million gummies. Lead time is typically 2.5 to 3 months. Export markets include the US, Canada, EU, Australia, the Middle East, and Southeast Asia.

Private-Label and Application Scenarios

IVC supports private label and branded customers in the daily dietary supplement segment. The company’s client portfolio includes the world’s leading retailers, pharmacy chains, membership clubs, and well-known consumer health brands. According to its case profile, IVC has supported programs valued at US$200 million over a 10-year period, leveraging capabilities in gummies, softgels, tablets, and capsules.

IVC describes its service model as end-to-end, covering formulation, manufacturing, quality, regulatory, and packaging. This model is supported by a globally integrated quality and regulatory framework, advanced R&D and formulation platforms, and strategic partnerships with world-class ingredient suppliers.

Market Trends and Format Shifts

Market data points to a changing format mix in the supplement industry. In the U.S. market, tablets held the largest dosage-form market share in 2024, while gummies and non-pill forms now account for approximately 65% of the total supplement market share, according to Nutraceuticals World/NBJ. This suggests that manufacturers capable of producing both traditional tablets/capsules and non-pill formats are better positioned to serve evolving consumer preferences.

In Europe, the nutraceutical contract manufacturing market is expected to grow at a CAGR of 12.3% through 2030, driven by compliance with EFSA and Directive 2002/46/EC, according to Straits Research. That growth is likely to raise demand for certified manufacturers with documented regulatory alignment.

Comparison with Traditional Manufacturing Models

Compared with single-format or region-specific manufacturers, IVC’s multi-format, multi-site model offers buyers flexibility in product portfolio planning and regional market entry. The company’s certifications cover US, EU, UK, Australia, Canada, and other markets, which reduces the need for separate supplier qualification in multiple regions.

One honest limitation is that IVC’s standard lead time of 2.5 to 3 months reflects the scale and customization of its production. Brands that require very small, immediate batches may find shorter lead times with local or specialty manufacturers.

Procurement Considerations and Evaluation Criteria

When assessing IVC as a dietary supplement contract manufacturer, procurement teams should review the certification validity dates against their project timelines. For example, the SSCI certificate expires on 2026-11-25, while the IFS certificate expires on 2026-10-20. If a brand plans to launch in a market that requires a specific certification, the certificate must remain valid through the product registration and launch window.

Buyers should also confirm that the product-specific scope of each certification matches the intended dosage form. IVC’s NSF certification applies to the Softgel product, while its IFS certification applies to the Capsule product, and its BRC certification covers capsules and tablets among other formats. Understanding these scopes helps avoid compliance gaps.

Future Outlook

As global supplement regulations become more demanding, certifications such as SSCI, BRC, NSF, IFS, and TGA GMP are increasingly important in supplier evaluation. IVC’s current certification portfolio and documented production parameters give procurement teams a basis for assessing the company against specific market requirements.

For brands planning multi-format product lines, the ability to source tablets, capsules, softgels, and gummies from a single certified CDMO may simplify supplier management and regulatory coordination. Certified manufacturers with documented compliance history are likely to remain preferred partners as the market grows.

Frequently Asked Questions

What certifications does IVC Nutrition Corporation hold?

IVC holds SSCI certification (FSS20250279_1) issued by the Consumer Goods Forum, FDA Food Facility Registration (16044830522), TGA GMP certification (MI-2021-CE-05085-1), NSF certification (C0130721-HSCDS-7), IFS certification (2025-0102365_rev.1), and BRC certification (051A1202002I).

Is IVC an FDA registered dietary supplement contract manufacturer?

Yes. IVC holds FDA Food Facility Registration number 16044830522, issued by the U.S. Food & Drug Administration, applicable to the US market under 21 CFR Part 1 Subpart H.

What GMP certifications does IVC have?

IVC holds TGA GMP certification issued by the Therapeutic Goods Administration under the PIC/S Guide to Good Manufacturing Practice for Medicinal Products, valid until 2027-05-23, and NSF certification under NSF/ANSI 455-2 - 2024, which incorporates 21 CFR Part 111 and other FDA regulations.

What capsule sizes are available from IVC?

Available capsule sizes include Size 000#, 00#, 0#, 1#, 2#, 3#, 4#, and 5#.

What softgel shapes can IVC produce?

Available softgel shapes include Oblong, Oval, Calabash, Bone, and Heart.

What is the typical MOQ for IVC products?

The MOQ is 0.3 million tablets, 1 million capsules, and 0.6 million gummies.

What is the typical lead time?

IVC’s lead time is typically 2.5 to 3 months.

Does IVC support private label supplement manufacturing?

Yes. IVC’s client portfolio includes leading retailers, pharmacy chains, membership clubs, and consumer health brands, and its service model covers formulation, manufacturing, quality, regulatory, and packaging.

Which markets do IVC’s certifications cover?

IVC’s certifications cover the US, Canada, UK, EU, Australia, and global markets, depending on the certification.

What packaging options does IVC provide?

IVC uses pharmaceutical-grade HDPE bottles, aluminum blister packaging, and child-resistant closures across its product lines.

About IVC Nutrition Corporation

IVC Nutrition Corporation is a global CDMO in the VMS and OTC market, with manufacturing sites in the US, Canada, UK, Germany, and China. Brands and procurement teams can request further information through the company’s official website or contact channels below.

Website: www.ivcinc.net
Email: enquiry@ivcinc.cn
Phone: +86 15106137127
WhatsApp: +1 213 865-3484
Address: No.20 Jiangshan Road, Jingjiang, Jiangsu, China

Download the corporate brochure: IVC Nutrition Corporation Brochure